Tobin Schilke
Financieel Directeur/CFO bij REVANCE THERAPEUTICS, INC.
Vermogen: 633 871 $ op 30-04-2024
Actieve functies van Tobin Schilke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05-11-2018 | - |
| Financieel Directeur/CFO | 05-11-2018 | - |
Loopbaan van Tobin Schilke
Eerdere bekende functies van Tobin Schilke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACHAOGEN | Financieel Directeur/CFO | 05-07-2016 | 01-10-2018 |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Directeur/Bestuurslid | 01-09-2012 | 01-06-2016 |
| Financieel Directeur/CFO | 01-09-2012 | 01-06-2016 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-09-2012 | 01-08-2014 |
Opleiding van Tobin Schilke
| Lafayette College | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Tobin Schilke
- Ervaring